Información del artículo
El Texto completo está disponible en PDF
Bibliografía
[1.]
M.S. Kramer, R. Kakuma.
Optimal duration of exclusive breastfeeding. (Cochrane Review).
The Cochrane Library, Issue 1,
[3.]
D. Bick.
The benefits of breastfeeding for the infant.
Br J Midwif, 7 (1999), pp. 312-319
[4.]
American Academy of Pediatrics.
Commitee on Nutrition. Comentary on breast-feeding and infant formulas, in-cluding proposed standards for formulas.
Pediatrics, 57 (1976), pp. 278-282
[5.]
ESPGAN Committee on Nutrition.
Guidlines on infant nutrition I. Recommendation for the composition of an adapted formula.
Acta Pediatr Scand, 262 (1977), pp. 1-22
[6.]
ESPGAN Committee on Nutrition.
Guidlines on infant nutrition II. Recommendation for the composition of followup formula and Beikost.
Acta Pediatr Scand, 287 (1981), pp. 1-25
[7.]
ESPGAN Committee on Nutrition.
Comment on the composition of cow's milk based follow-up formula.
Acta Pediatr Scand, 79 (1990), pp. 250-254
[8.]
ESPGAN Committee on Nutrition.
Comment on the content and composition of lipids in infant formulas.
Acta Pediatr Scand, 80 (1991), pp. 887-896
[9.]
Directiva de la Comision 91/321, relativa a los preparados para lactantes y preparados de continuacion.
Diario Oficial de las Comunidades Europeas de, (4-7-1991), pp. 35-49
[10.]
Directiva 96/4/CE de la Comision, de 16 de febrero de 1996 por la que se modifica la Directiva de 91/321/CEE relativa a los preparados para lactantes y preparados de continuacion.
Diario Oficial de las Comunidades Europeas de, (28-2-1996), pp. 12-16
[11.]
Boletin Oficial del Estado, Real Decreto 1408/1992, de 20 de noviembre, por el que se aprueba la Reglamentacion Tecnico- Sanitaria Especifica de los preparados para lactantes y preparados de continuacion.
BOE num. 11, de, (13-1-1993), pp. 793-800
[12.]
WHO/UNICEF.
International code of marketing of breastmilk substitutes,
[13.]
Codex Alimentarius Commission.
[14.]
J.M. Moreno Villares.
Formulas para lactantes sanos.
An Esp Pediatr, 54 (2001), pp. 147-150
[15.]
Commission Directive 1999/50/EC of May 25, 1999, amending Directive 91/321/EEC on infant formulae and follow on formulae.
Official J Eur Comm, (1999), pp. L139
[16.]
A. Levtchencko, B. Hauser, Y. Vandenplas.
Anthropometry and nutritional value of a whey adapted formula or a thickened AR-formula in term born infants [abstract].
J Ped Gastroenterol Nutr, 24 (1997), pp. 491
[17.]
D. Bosscher, M. Van Caillie-Bertrand, K. Van Dick, H. Robberecht, R. Van Cauwenbergh, H. Deelstra.
Thickening infant formula with digestible and indigestible carbohydrate: Availability of calcium, iron and zinc in vitro.
J Ped Gastroenterol Nutr, 30 (2000), pp. 373-378
[18.]
Y. Vandenplas, A. Ashkenazi, D. Belli.
A proposition for the diagnosis and treatment of gastro-oesophageal reflux disease in children: a report from working group on gastro-oesophageal reflux disease. Working Group of the European Society of Paediatric Gastroenterology and Nutrition (ESPGHAN).
Eur J Pediatr, 152 (1993), pp. 704-711
[19.]
Y. Vandenplas, D. Belli, P. Benhamou.
A critical appraisal of current management practices for infant regurgitation-recommendations of a working party.
Eur J Pediatr, 156 (1997), pp. 343-357
[20.]
P.J. Aggett, C. Agostoni, O. Goulet, B. Koletzko, H.L. Lafeber, K.F. Michaelsen, et al.
Antireflux or antiregurgitation milk products for infants and young children: A commentary by ESPGHAN Committee on Nutrition.
J Ped Gastroenterol Nutr, 34 (2002), pp. 496-498
[21.]
P.T. Quinlan, S. Lockton, J. Irwin, A.L. Lucas.
The relationship between stool hardness and stool composition in breast- and formula-fed infants.
J Ped Gastroenterol Nutr, 20 (1995), pp. 81-90
[22.]
R.G. Jensen.
Lipids in human milk-composition and fat-soluble vitamins.
Textbook of Gastroenterology an nutrition in infancy, 2nd ed, pp. 157-220
[23.]
P.W. Parodi.
Positional distribution of fatty acids in tryglicerides from milk of several species of mammals.
Lipids, 17 (1982), pp. 437-442
[24.]
V. Carnielli, I. Luijendijk, J. Van Goudoever, E. Sulkers, A. Boerlage, H. Degenhart, et al.
Structural position and amount of palmitic acid in infant formulas: Effects on fat, fatty acid and mineral balance.
J Ped Gastroenterol Nutr, 23 (1996), pp. 553-560
[25.]
A. Lopez-Lopez, A. Castellote-Bargallo, C. Campy-Folgoso, M. Rivero-Urgel, R. Tormo Carnice, D. Infante Pina, et al.
The influence of dietary palmitic acid triacylglyceride position on the fatty acid, calcium and magnesium contents of at term newborn faeces.
Early Hum Dev, 65 (2001), pp. S83-S94
[26.]
K. Kennedy, M.S. Fewtrel, R. Morley, R. Abbott, P.T. Quinlan, J.C.K. Wells, et al.
Double-blind, randomized trial of a synthetic triacylglycerol in formula-fed term infants: effects on stool biochemistry, stool characteristics and bone mineralization.
Am J Clin Nutr, 70 (1999), pp. 920-927
[27.]
K. Simmer.
Longchain polyunsaturated fatty acid supplementation in infants born at term,
[28.]
N. Auestad, R. Halter, R. Hall, M. Blatter, M. Bogle, W. Burks, et al.
Growth and development in term infants fed longchain polyunsaturated fatty acids: a double-masked, randomized, parallel, prospective, multivariate study.
Pediatrics, 108 (2001), pp. 372-381
[29.]
B. Koletzko, C. Agostoni, S.E. Carlson, T. Clandinin, G. Hornstra, M. Neuringer, et al.
Long chain polyunsaturated fatty acids (LC-pUFA) and perinatal development.
Acta Paediatr, 90 (2001), pp. 460-464
[30.]
J.L. Leach, J.H. Baxter, B.E. Molitor, M.B. Ramstack, M.L. Masor.
Total potentially available nucleosides of human milk by stage of lactation.
Am J Clin Nutr, 61 (1995), pp. 1224-1230
[31.]
L.K. Pickering, D.M. Granoff, J.R. Erickson, M.L. Masor, C.T. Cordle, a.l. Schaller JP et.
Modulation of the immune system by human milk and infant formula containing nucleotides.
Pediatrics, 101 (1998), pp. 242-249
[32.]
K. Tsou Yau, C. Huang, W. Chen, S. Chen, Y. Chou, F. Huang, et al.
Effect of nucleotides on diarrhea and immune responses in healthy term infants in Taiwan.
J Ped Gastroenterol Nutr, 36 (2003), pp. 37-43
[33.]
P. McVeagh, J. Brand.
Human milk oligosaccharides: only de breast.
J Paediatr Child Health, 33 (1997), pp. 281-286
[34.]
C. Kunz, S. Rudlolf, W. Baier, N. Klein, S. Strobel.
Oligosaccharides in human milk: Structural, functional and metabolic aspects.
Annu Rev Nutr, 20 (2000), pp. 699-722
[35.]
G. Moro, I. Minoli, M. Mosca, S. Fanaro, J. Jelinek, B. Stahl, et al.
Dosage-related bifidogenic effects of Galacto- and fructooligosaccharides in formula-fed term infants.
J Ped Gastroenterol Nutr, 34 (2002), pp. 291-295
[36.]
Scientific Committee on Food (2001).
Statement on the use of resistant short chain carbohydrates (oligofructose and oligogalactose) in infant formulae and follow-on formulae.
Expressed on 26 September, (2001),
[37.]
Scientific Committee on Food (2001).
Additional statement on the use of resistant short chain carbohydrates (oligofructosyl- saccharosa and oligogalactosyl-lactose) in infant formulae and follow-on formulae.
Expressed on 13 December, (2001),
[38.]
J. Ghisolfi, M. Roberfroid, J. Rigo, G. Moro, I. Polanco.
Infant formula supplemented with probiotics or prebiotics: never, now or someday?.
J Ped Gastroenterol Nutr, 35 (2002), pp. 467-468
[39.]
N.C.R. Raiha, A. Fazzolari, C. Cajozzo.
Whey modified infant formula with protein-energy ratio of 1,8 g/100 kcal is adequate and safe from birth to 4 month.
J Ped Gastroenterol Nutr, 31 (2000), pp. s94
[40.]
ESPGAN Committee on Nutrition of the Preterm Infant.
Nutrition and feeding of premature infants.
Acta Paediatr Scand, Suppl 336, (1987), pp. 1-14
[41.]
Nutrition Committee, Canadian Paediatric Society.
Nutrient needs and feeding of premature infants.
Can Med Assoc J, 152 (1995), pp. 1765-1785
[42.]
American Academy of Pediatrics.
Committee on Nutrition. Subcommittee on Nutrition of Preterm Infants. Guidelines of the evaluation of the safety and suitability of new infant formulas for feeding preterm infants.
Report for the Food and Drug Administration, pp. 1-31
[43.]
C.J. Klein.
Nutrient Requirements for preterm infant formulas.
J Nutr, 132 (2002), pp. S1395S-S1577S
Copyright © 2004. Elsevier España, S.L.. Todos los derechos reservados